Tighter lending standards and high interest rates will likely push the economy into a recession this year. Therefore, it could be wise to sell fundamentally weak stocks Owens & Minor.
Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before.